Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) EBT Margin (2020 - 2025)

Historic EBT Margin for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to 52.18%.

  • IDEAYA Biosciences' EBT Margin changed N/A to 52.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 77.97%, marking a year-over-year increase of 56526300.0%. This contributed to the annual value of 4671.07% for FY2024, which is 40962200.0% down from last year.
  • IDEAYA Biosciences' EBT Margin amounted to 52.18% in Q3 2025.
  • IDEAYA Biosciences' EBT Margin's 5-year high stood at 52.18% during Q3 2025, with a 5-year trough of 2059.11% in Q4 2024.
  • Moreover, its 5-year median value for EBT Margin was 359.01% (2022), whereas its average is 494.08%.
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 1327100bps in 2022, then tumbled by -9903500bps in 2024.
  • IDEAYA Biosciences' EBT Margin (Quarter) stood at 620.16% in 2021, then fell by -6bps to 657.46% in 2022, then crashed by -63bps to 1068.77% in 2023, then tumbled by -93bps to 2059.11% in 2024, then skyrocketed by 103bps to 52.18% in 2025.
  • Its last three reported values are 52.18% in Q3 2025, 2059.11% for Q4 2024, and 1068.77% during Q4 2023.